ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.00%
S&P ASX All Technology
3,102.60
0.00%
Brent Oil
81.835
3.14%
US Dollar vs AUD
1.51289
-0.42%
Bitcoin
69,593.10
-0.09%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Exscientia PLC (EXAI)

  7. Exscientia PLC (EXAI) News

EXAI

Exscientia (EXAI)

Exscientia PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EXAI
DateTimeSourceHeadlineSymbolCompany
10/06/202419:45PR Newswire (US)June 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EXAINASDAQ:EXAIExscientia PLC
07/06/202406:16Business WireExscientia ernennt neue Führungskräfte zur Stärkung der Auswirkungen integrierter Technologien und um den Schwerpunkt auf klinische Entwicklungskompetenz in der Onkologie zu richtenNASDAQ:EXAIExscientia PLC
07/06/202406:12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
07/06/202405:49Business WireExscientia nomme de nouveaux dirigeants pour accentuer l'impact des technologies intégrées et recentrer l'expertise en développement clinique sur l'oncologieNASDAQ:EXAIExscientia PLC
06/06/202421:00Business WireExscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in OncologyNASDAQ:EXAIExscientia PLC
05/06/202419:45PR Newswire (US)Shareholders that lost money on Exscientia plc(EXAI) should contact The Gross Law Firm about pending Class Action - EXAINASDAQ:EXAIExscientia PLC
31/05/202404:30Business WireExscientia participera à des conférences d'investisseurs au mois de juinNASDAQ:EXAIExscientia PLC
31/05/202403:58Business WireExscientia präsentiert sich auf kommenden Investorenkonferenzen im JuniNASDAQ:EXAIExscientia PLC
30/05/202421:00Business WireExscientia to Present at Upcoming Investor Conferences in JuneNASDAQ:EXAIExscientia PLC
29/05/202419:45PR Newswire (US)Exscientia plc Sued for Securities Law Violations - Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
24/05/202406:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
21/05/202421:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
21/05/202421:00Business WireExscientia Business Update for First Quarter 2024NASDAQ:EXAIExscientia PLC
21/05/202419:45PR Newswire (US)Shareholders of Exscientia plc Should Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
15/05/202405:52Business WireExscientia legt am 21. Mai 2024 das Geschäftsergebnis für das erste Quartal 2024 vorNASDAQ:EXAIExscientia PLC
15/05/202401:13Business WireExscientia publiera ses résultats financiers du premier trimestre 2024 le 21 mai 2024NASDAQ:EXAIExscientia PLC
14/05/202421:00Business WireExscientia to Report First Quarter 2024 Financial Results on May 21, 2024NASDAQ:EXAIExscientia PLC
14/05/202419:45PR Newswire (US)Shareholders that lost money on Exscientia plc(EXAI) should contact The Gross Law Firm about pending Class Action - EXAINASDAQ:EXAIExscientia PLC
07/05/202419:45PR Newswire (US)Exscientia plc Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
04/05/202403:27PR Newswire (US)Investors in Exscientia plc Should Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
21/03/202422:26IH Market NewsU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor DeclinesNASDAQ:EXAIExscientia PLC
21/03/202422:00Business WireExscientia Business and Financial Update for the Full Year 2023NASDAQ:EXAIExscientia PLC
15/03/202402:29Business WireExscientia présentera ses résultats financiers pour l’année 2023 le 21 mars 2024NASDAQ:EXAIExscientia PLC
15/03/202402:29Business WireExscientia berichtet am 21. März 2024 über die Finanzergebnisse für das Gesamtjahr 2023NASDAQ:EXAIExscientia PLC
14/03/202422:00Business WireExscientia to Report Full Year 2023 Financial Results on March 21, 2024NASDAQ:EXAIExscientia PLC
01/03/202400:20Business WireExscientia präsentiert auf kommenden Investorenkonferenzen im MärzNASDAQ:EXAIExscientia PLC
29/02/202401:08Business WireExscientia participera à de prochaines conférences d'investisseurs au mois de marsNASDAQ:EXAIExscientia PLC
28/02/202423:00Business WireExscientia to Present at Upcoming Investor Conferences in MarchNASDAQ:EXAIExscientia PLC
13/02/202422:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
13/02/202403:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EXAIExscientia PLC
 Showing the most relevant articles for your search:NASDAQ:EXAI

Your Recent History

ASX
WBC
Westpac Banking
NYSE
MRK
Merck
NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
ASX
XFL
S&P ASX 50
ASX
WOW
Woolworths
ASX
ORG
Origin Energy
ASX
WDC
Westfield
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
FTSE
UKX
FTSE 100
ASX
TLS
Telstra
NYSE
NKE
Nike
ASX
BHP
BHP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved